Related Experiment Video

Updated: Jun 25, 2026

Influenza Virus Propagation in Embryonated Chicken Eggs
06:56

Influenza Virus Propagation in Embryonated Chicken Eggs

Published on: March 19, 2015

Prevention of influenza in mothers and infants

Rachel C Potter1, Bernard Gonik

  • 1Vaccine-Preventable Disease Epidemiologist, Michigan Department of Community Health, MI, USA. potterr1@michigan.gov

Expert Review of Vaccines
|February 7, 2009
PubMed

Insights

Pregnant women and infants face high influenza risks. Maternal vaccination is safe and effective, offering significant protection for newborns against severe illness.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatrics
  • Immunology

Background:

  • Pregnant women and infants under six months are highly susceptible to severe influenza complications, comparable to elderly and chronically ill individuals.
  • Current US FDA-licensed influenza vaccines lack approval for infants under six months.
  • Despite recommendations, influenza immunization rates remain low among pregnant women.

Discussion:

  • This study validates the Advisory Committee on Immunization Practices' recommendation for influenza vaccination during pregnancy.
  • The findings provide robust evidence supporting the neonatal benefits derived from maternal influenza immunization.
  • The data aim to increase provider and patient confidence in the safety and efficacy of antenatal influenza vaccination.

Key Insights:

  • Maternal influenza vaccination is a critical public health intervention for protecting both mother and neonate.
  • The study confirms the protective effects of maternal immunization extending to infants.
  • Influenza vaccination during pregnancy is well-founded and beneficial.

Outlook:

  • Further research could explore optimal timing and specific vaccine types for maternal immunization.
  • Continued efforts are needed to improve uptake of influenza vaccines in pregnant populations.
  • Long-term studies may elucidate the duration of neonatal protection conferred by maternal vaccination.

More Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations01:51

Vaccinations

Overview
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...